NZ701667A - Compositions and methods for biophotonic bone reconstruction - Google Patents

Compositions and methods for biophotonic bone reconstruction

Info

Publication number
NZ701667A
NZ701667A NZ701667A NZ70166713A NZ701667A NZ 701667 A NZ701667 A NZ 701667A NZ 701667 A NZ701667 A NZ 701667A NZ 70166713 A NZ70166713 A NZ 70166713A NZ 701667 A NZ701667 A NZ 701667A
Authority
NZ
New Zealand
Prior art keywords
biophotonic
compositions
methods
bone reconstruction
photoactivator
Prior art date
Application number
NZ701667A
Other languages
English (en)
Inventor
Remigio Piergallini
Nikolaos Loupis
Original Assignee
Klox Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klox Tech Inc filed Critical Klox Tech Inc
Publication of NZ701667A publication Critical patent/NZ701667A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/898—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L24/0084—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/32—Phosphorus-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/15—Heterocyclic compounds having oxygen in the ring
    • C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1545—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/442—Colorants, dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/32—Phosphorus-containing compounds
    • C08K2003/321—Phosphates
    • C08K2003/325—Calcium, strontium or barium phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Composite Materials (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ701667A 2012-05-30 2013-05-30 Compositions and methods for biophotonic bone reconstruction NZ701667A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261653101P 2012-05-30 2012-05-30
US201361777894P 2013-03-12 2013-03-12
PCT/CA2013/000532 WO2013177686A1 (en) 2012-05-30 2013-05-30 Compositions and methods for biophotonic bone reconstruction

Publications (1)

Publication Number Publication Date
NZ701667A true NZ701667A (en) 2017-05-26

Family

ID=49672237

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ701667A NZ701667A (en) 2012-05-30 2013-05-30 Compositions and methods for biophotonic bone reconstruction

Country Status (17)

Country Link
US (1) US11426463B2 (enExample)
EP (1) EP2854853B1 (enExample)
JP (1) JP2015519134A (enExample)
KR (1) KR20150023294A (enExample)
CN (1) CN104394888A (enExample)
AU (1) AU2013270353A1 (enExample)
BR (1) BR112014029801A2 (enExample)
CA (1) CA2873068A1 (enExample)
HK (1) HK1207300A1 (enExample)
IL (1) IL235687A0 (enExample)
IN (1) IN2014DN09950A (enExample)
MX (1) MX2014014458A (enExample)
NZ (1) NZ701667A (enExample)
RU (1) RU2014147975A (enExample)
SG (1) SG11201407276RA (enExample)
WO (1) WO2013177686A1 (enExample)
ZA (1) ZA201408483B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9834740B2 (en) * 2014-01-24 2017-12-05 The Procter & Gamble Company Photoactivators
JP2017509433A (ja) * 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. 組織充填剤組成物および使用方法
JP6158885B2 (ja) * 2015-10-14 2017-07-05 三菱電機株式会社 光源ユニット及び照明装置
ES2941364T3 (es) 2018-06-11 2023-05-22 Procter & Gamble Dispositivo fotoactivador para lavadora
KR102482319B1 (ko) * 2020-09-29 2022-12-29 주식회사 시지바이오 고탄성의 인산 칼슘계 주입형 골 이식재 조성물 및 이의 제조방법
KR20260032794A (ko) * 2024-08-30 2026-03-10 주식회사 덴큐임플란트 임플란트 서지컬 키트의 드릴링 온도를 이용한 인공지능 기반 골질 판별 시스템
CN119935694A (zh) * 2025-01-24 2025-05-06 北京大学第三医院(北京大学第三临床医学院) 一种骨组织多重特殊染色分析方法及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1259090B (it) 1992-04-17 1996-03-11 Fidia Spa Biomaterialli per protesi d'osso
GB9721585D0 (en) 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
DE60020526T2 (de) * 1999-02-04 2006-05-11 SDGI Holdings, Inc., Wilmington Osteogene pastenzusammensetzungen und ihre verwendung
CN1172681C (zh) 1999-08-18 2004-10-27 凌沛学 透明质酸口服美肤保健品
US7842300B2 (en) 2002-07-31 2010-11-30 Dentsply International, Inc. Bone repair putty
US8876532B2 (en) 2002-07-31 2014-11-04 Dentsply International Inc. Bone repair putty
JP2006508126A (ja) 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
CN102579162A (zh) 2003-09-23 2012-07-18 奥索康公司 可吸收的植入体和它们用于止血和治疗骨缺损的方法
ITPD20030286A1 (it) 2003-11-27 2005-05-28 Fidia Advanced Biopolymers Srl Strutture composite multistrato contenenti acido ialuronico
US20080199512A1 (en) 2005-09-02 2008-08-21 Steffi Dudek Oral Composition For Moisturizing Skin
US9132208B2 (en) * 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
ATE487459T1 (de) 2005-12-28 2010-11-15 Dentsply Int Inc Lichthärtbares knochenwachstumsmaterial zur behandlung von zahnknochendefekten
US8999933B2 (en) 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
JP2007197371A (ja) 2006-01-26 2007-08-09 Yaizu Suisankagaku Industry Co Ltd 美肌促進剤及び美容健康食品
US20110206768A1 (en) 2006-12-08 2011-08-25 The University Of Waikato Medical preparation
CN101677957A (zh) * 2007-02-05 2010-03-24 卡比兰生物外科公司 用于递送生物活性试剂的聚合物制剂
CA2695386A1 (en) 2007-08-01 2009-02-05 The Johns Hopkins University Photoinitiated tissue filler
US9314545B2 (en) * 2008-04-15 2016-04-19 Life Science Enterprises, Inc. Minimally invasive treatment of vertebra (MITV) using a calcium phosphate combination bone cement
SG177635A1 (en) 2009-07-17 2012-03-29 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease

Also Published As

Publication number Publication date
EP2854853A4 (en) 2016-01-13
JP2015519134A (ja) 2015-07-09
US20150119789A1 (en) 2015-04-30
WO2013177686A1 (en) 2013-12-05
CA2873068A1 (en) 2013-12-05
RU2014147975A (ru) 2016-07-20
US11426463B2 (en) 2022-08-30
EP2854853B1 (en) 2019-08-21
EP2854853A1 (en) 2015-04-08
IN2014DN09950A (enExample) 2015-08-14
IL235687A0 (en) 2015-01-29
BR112014029801A2 (pt) 2017-06-27
HK1207300A1 (en) 2016-01-29
AU2013270353A1 (en) 2014-11-27
KR20150023294A (ko) 2015-03-05
CN104394888A (zh) 2015-03-04
MX2014014458A (es) 2015-08-14
SG11201407276RA (en) 2015-03-30
ZA201408483B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
IN2014DN09950A (enExample)
MX2015017974A (es) Composiciones biofotónicas que comprenden un cromóforo y un agente gelificante para el tratamiento de heridas.
BR112015006426A2 (pt) composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos
CL2015001322A1 (es) Sistemas y métodos de cartílago triturado.
BR112013032229A2 (pt) método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição
NZ598791A (en) Anti-gcc antibody molecules and related compositions and methods
CA2905610C (en) Hyaluronic acid derivatives
PL2851096T3 (pl) Kompozycja do naprawy tkanki chrzęstnej, sposób jej wytwarzania oraz jej zastosowanie
CO7461129A2 (es) Beta-glucosidasa de magnaporthe grisea
BR112012028194A2 (pt) composição, e, processo para preparação da composição
AP2012006569A0 (en) Systems, methods, and compositions relating to combustible biomaterials
BR112013028222A2 (pt) Composição polimérica para dispositivos elétricos
MY161601A (en) Films and compositions comprising the same
IN2014CN03509A (enExample)
CL2013001071A1 (es) Metodo para sinterizar una composicion que comprende dos componentes en povo, donde la actividad de agua del primer componente es superior a la de la segunda, que comprende calentar a una temperatura superior a la temperatura de transicion vitrea del primer componente pero inferior a la del segundo.
MX358132B (es) Solucion de trombina y metodos de uso de esta.
BR112015010475A2 (pt) composição granular de limpeza de superfícies, mistura de limpeza e método para limpeza de uma superfície
WO2013162933A3 (en) Active halogen antimicrobial composition and method of use
JP2015519134A5 (enExample)
MX2014013049A (es) Composiciones y metodos para sulfato de heparan como un biomarcador para rechazo de trasplante.
BR112014018874A8 (pt) Dispersão aquosa livre de cimento, processos para preparar uma dispersão aquosa, e uma composição de polímero em pó, composição de polímero em pó, uso de uma dispersão aquosa, formulação aquosa de composições de fixação hidráulicas, e, composição de fixação hidráulica na forma de pó
TN2016000206A1 (en) Combination of glycosaminoglycans and cyclodextrins.
MX2015013122A (es) Composiciones hidrofílicas de hialuronato modificado, revestimientos y métodos.
MX368061B (es) Proceso de radioetiquetado.
WO2013128173A3 (en) Skincare compositions

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed